Previous Close | 686.00 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's Range | 687.00 - 687.00 |
52 Week Range | 687.00 - 687.00 |
Volume | |
Avg. Volume | N/A |
Market Cap | N/A |
Beta (5Y Monthly) | 0.65 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
The board of Perrigo Company plc ( NYSE:PRGO ) has announced that it will pay a dividend on the 18th of June, with...
Insurance company Progressive stock slumps after reporting a second-quarter earnings miss, revenue beat. Amazon announces this year's Prime Day was its biggest sales event on record. Pharmaceutical manufacturer Perrigo has received FDA approval on its over-the-counter birth control pill, Opill.
Perrigo's Opill oral contraceptive has become the first over-the-counter birth control approved by the U.S. Food and Drug Administration. Ibis Reproductive Health President Kelly Blanchard tells Yahoo Finance Live what the approval means for contraceptive market.